Neuroderm Raises $16 Million for Parkinson’s Cure

Israel’s NeuroDerm Ltd., announced that it raised $16 million to further the clinical and regulatory development of its Levodopa products, combating Parkinson’s disease. ND0612L, NeuroDerm’s More...